A detailed history of Mather Group, Llc. transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Mather Group, Llc. holds 7,143 shares of CDMO stock, worth $86,716. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,143
Previous 7,143 -0.0%
Holding current value
$86,716
Previous $51,000 58.82%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 08, 2024

BUY
$5.86 - $8.79 $41,857 - $62,786
7,143 New
7,143 $47,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $755M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Mather Group, Llc. Portfolio

Follow Mather Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.